Sort
50,496 grants matching “lung cancer”
Role and Regulation of Id1 during Breast Cancer Metastasis Initiation
$491,039Robert I Benezra · Sloan-Kettering Inst Can Research · P01 · FY2014 · CA
Predictors of Adult Leukemia
$491,008Julie Ann Ross · University Of Minnesota · R01 · FY2007 · CA
Prospective Studies of Diet and Cancer in Men and Wonen
$490,980Walter C. Willett · Harvard School Of Public Health · P01 · FY2006 · CA
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
$490,856Kristine L Kwekkeboom · University Of Wisconsin-Madison · R01 · FY2015 · NR
Targeting stem-like cells and their niche in pancreatic cancer
$490,849Tuomas Tammela · Sloan-Kettering Inst Can Research · R37 · FY2025 · CA
(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCIS
$490,842Eun-Sil Shelley Hwang · Duke University · R01 · FY2017 · CA
(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCIS
$490,842Eun-Sil Shelley Hwang · Duke University · R01 · FY2015 · CA
(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCIS
$490,842Eun-Sil Shelley Hwang · Duke University · R01 · FY2016 · CA
Bronchoscopic Steerable Needles for Transparenchymal Access to Lung Nodules
$490,749Ron Alterovitz · Univ Of North Carolina Chapel Hill · R01 · FY2020 · EB
Unraveling mechanisms of tumor suppression in lung cancer
$490,735Monte Meier Winslow · Stanford University · R01 · FY2021 · CA
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
$490,715Joseph B. Margolick · Johns Hopkins University · U01 · FY2021 · HL
Defining epithelial polarity cues that direct cell fate
$490,684Xaralabos Varelas · Boston University Medical Campus · R01 · FY2020 · HL
Defining epithelial polarity cues that direct cell fate
$490,684Xaralabos Varelas · Boston University Medical Campus · R01 · FY2022 · HL
Defining epithelial polarity cues that direct cell fate
$490,684Xaralabos Varelas · Boston University Medical Campus · R01 · FY2021 · HL
Defining epithelial polarity cues that direct cell fate
$490,684Xaralabos Varelas · Boston University Medical Campus · R01 · FY2023 · HL
The Positively Quit Trial: Addressing disproportionate smoking rates among people living with HIV
$490,682Stephanie Lynn Marhefka · University Of South Florida · R01 · FY2024 · CA
Imaging the multifaceted response to a bispecific antibody therapy
$490,678Bernadette Marquez-Nostra · University Of Alabama At Birmingham · R01 · FY2023 · CA
VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer
$490,625Mathew L Thakur · Thomas Jefferson University · R01 · FY2016 · CA
Dual-Stimuli Responsive Antibiotic-Loaded Nanoparticles: A New Strategy to Overcome Antimicrobial Resistance
$490,606Shaoqin - Gong · University Of Wisconsin-Madison · R01 · FY2023 · AI
Synthetic lethality by targeting the core senescent mechanism in lung cancer.
$490,590Xiao-Fan Wang · Duke University · R01 · FY2021 · CA
Targeting stem-like cells and their niche in pancreatic cancer
$490,568Tuomas Tammela · Sloan-Kettering Inst Can Research · R37 · FY2020 · CA
Discovery and optimization of novel mutant-selective allosteric inhibitors of EGFR T790M
$490,549Michael J Eck · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Discovery and optimization of novel mutant-selective allosteric inhibitors of EGFR T790M
$490,549Michael J Eck · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Hexokinase 2 and cancer therapy
$490,487Nissim Hay · University Of Illinois At Chicago · R01 · FY2021 · CA
Career Development in Cancer Prevention Research at FCCC
$490,485Paul F. Engstrom · Fox Chase Cancer Center · R25 · FY2007 · CA